×
English
हिंदी
ગુજરાતી
Home
My Feed
Remove Ads
Get Premium Content
Go Pro @₹99
Credit Cards
Instant Loans
Apply Now
Credit Score
Refer & Earn ₹500
Refer Now
Finance Tracker
Learning Curve
Fixed Deposits
Business Loan
Markets
Markets
FII & DII Activity
Corporate Action
Research Advice
Earnings
Technical Trends
Stock Deals
Intraday Large Deals
Bonds
Webinar
Pre Market
Stock Scanner
Sector Analysis
Unlisted Shares
Stock Updates
PRO Stock Lists
Monsoon Tracker
Seasonality Analysis
Crypto Dashboard
Web Stories
Tax Calculator
Forum
Gold Rate
Silver Rate
IFSC Code Finder
Storyboard18
IPO
Economic Indicators
Economic Calendar
Global Markets
US Markets
ETFs
Indian Indices
News
News
Tech/Startups
Auto
Research
Opinion
Politics
Personal Finance
EPF Guide
Real Estate
Portfolio
Watchlist
Personal Finance
Personal Finance
Loans
Fixed Deposit Comparison
Fixed Deposit Interest Calculator
Moneycontrol - SecureNow Health Insurance ratings
Mutual Funds
Mutual Funds
Performance Tracker
Top ranked funds
My Portfolio
Top performing Categories
Forum
New Fund Offers
MF Simplified
Commodities
Mutual Funds
Gold Rate
Silver Rate
Currencies
Cryptocurrency
Media
Live TV & Shows
Video
Podcast
Photos
Invest Now
Trade like Experts
Invest in Unlisted Shares
Specials
Pharma Industry Conclave
Unlocking opportunities in Metal and Mining
#MFSummit2025
Moneycontrol mutual fund summit 2025
Advanced Technical Charts
International
Get App
Be a
Pro
Home
PRO
Markets
News
Editor’s Picks
Tech
India
Learning Curve
Portfolio
Watchlist
Commodities
MF
Personal Finance
Forum
Videos
you are here:
Home
News
Weight Loss Drug
Weight Loss Drug
Ads
How Eli Lilly’s weight-loss drug Mounjaro gained early lead against Novo Nordisk’s Wegovy in India
Roche to buy 89bio for up to $3.5 billion in obesity push
India bulk drug makers start preparing for Ozempic patent expiry
Chart of the Day: Weight loss drugs are making their presence felt in Indian pharma market
Lilly to launch Mounjaro pen in India to compete with Novo's weight-loss drug Wegovy
Novo Nordisk launches blockbuster weight loss drug Wegovy in India
Mounjaro side effects revealed: Decreased appetite, mild nausea and more
Is Ozempic beneficial for you? Nutritionist explains how it can diminish your natural glow
Eli Lilly may manufacture weight-loss drug Mounjaro in India in future, says CEO David Ricks
Move over Ozempic. Mounjaro is the new weight loss drug in the market
Eli Lilly plans launch of weight-loss drug in emerging markets by 2026, CFO says
Ozempic: A miracle weight-loss drug or dangerous trend? We examine
Weight loss drug opportunity is increasingly coming into focus for Indian pharma
Novo Nordisk falls most on record after new weight drug disappoints
Morepen Labs forays into obesity market with nutrition products and health-tracking app
Health benefits of matcha tea: The superfood to lose weight, boost immunity, keep skin smooth
Weight-Loss Drug Sales Forecast To Hit $150 Billion By 2030 | Wegovy & Zepbound Lead The Charge
Open to market Eli Lilly’s weight loss drugs in India: Cipla CEO
Biocon leads India push into weight loss drugs as patents lapse
Ozempic obsession: Hollywood’s weight loss fixation; why it is in spotlight once again
Anti-Obesity Drug: Science Finally Lets You Lose Weight Without Diet Or Exercise
Home
Markets
Loans
SPIN
2
WIN
News
Portfolio